Literature DB >> 25083141

Insights into synaptic function from mouse models of human cognitive disorders.

Jessica L Banko1, Justin Trotter2, Edwin J Weeber2.   

Abstract

Modern approaches to the investigation of the molecular mechanisms underlying human cognitive disease often include multidisciplinary examination of animal models engineered with specific mutations that spatially and temporally restrict expression of a gene of interest. This approach not only makes possible the development of animal models that demonstrate phenotypic similarities to their respective human disorders, but has also allowed for significant progress towards understanding the processes that mediate synaptic function and memory formation in the nondiseased state. Examples of successful mouse models where genetic manipulation of the mouse resulted in recapitulation of the symptomatology of the human disorder and was used to significantly expand our understanding of the molecular mechanisms underlying normal synaptic plasticity and memory formation are discussed in this article. These studies have broadened our knowledge of several signal transduction cascades that function throughout life to mediate synaptic physiology. Defining these events is key for developing therapies to address disorders of cognitive ability.

Entities:  

Keywords:  Alzheimer’s disease; Angelman syndrome; Reelin; Rubinstein-Taybi syndrome; autism; hippocampus; knockout mouse; neurofibromatosis type 1; secretin; synaptic plasticity

Year:  2011        PMID: 25083141      PMCID: PMC4114080          DOI: 10.2217/fnl.10.80

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  102 in total

1.  The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.

Authors:  J Van Rampelbergh; P Poloczek; I Françoys; C Delporte; J Winand; P Robberecht; M Waelbroeck
Journal:  Biochim Biophys Acta       Date:  1997-06-27

2.  A sibship with a neuronal migration defect, cerebellar hypoplasia and congenital lymphedema.

Authors:  J O Hourihane; C P Bennett; R Chaudhuri; S A Robb; N D Martin
Journal:  Neuropediatrics       Date:  1993-02       Impact factor: 1.947

3.  The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons.

Authors:  S Hirotsune; T Takahara; N Sasaki; K Hirose; A Yoshiki; T Ohashi; M Kusakabe; Y Murakami; M Muramatsu; S Watanabe
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

4.  Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function.

Authors:  R G Morris; J J Hagan; J N Rawlins
Journal:  Q J Exp Psychol B       Date:  1986-11

5.  Lissencephaly with cerebellar hypoplasia (LCH): a heterogeneous group of cortical malformations.

Authors:  M E Ross; K Swanson; W B Dobyns
Journal:  Neuropediatrics       Date:  2001-10       Impact factor: 1.947

6.  Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones.

Authors:  J D Gardner; T P Conlon; T D Adams
Journal:  Gastroenterology       Date:  1976-01       Impact factor: 22.682

7.  Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.

Authors:  Uwe Beffert; Gerardo Morfini; Hans H Bock; Huichuan Reyna; Scott T Brady; Joachim Herz
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

8.  CBP histone acetyltransferase activity is a critical component of memory consolidation.

Authors:  Edward Korzus; Michael G Rosenfeld; Mark Mayford
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

9.  Reelin activates SRC family tyrosine kinases in neurons.

Authors:  Hans H Bock; Joachim Herz
Journal:  Curr Biol       Date:  2003-01-08       Impact factor: 10.834

Review 10.  Ras-related and MAPK signalling in neuronal plasticity and memory formation.

Authors:  C Mazzucchelli; R Brambilla
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.